<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="24916">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01717014</url>
  </required_header>
  <id_info>
    <org_study_id>COVLARO0286</org_study_id>
    <nct_id>NCT01717014</nct_id>
  </id_info>
  <brief_title>Radial Reload Open LAR Case Series</brief_title>
  <official_title>Evaluating the Radial Reload Stapler With Tri-Staple TM Technology During Open Low Anterior Resection for Rectal Cancer: A Prospective Multicenter Case Series</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Covidien</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Providence Medical Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of South Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Covidien</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to evaluate the safety and feasibility of the Radial
      Reload Stapler during open LAR for rectal cancer. The surgeon will complete questionnaires
      relating to the function of the device.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Staple Line</measure>
    <time_frame>Operative</time_frame>
    <safety_issue>No</safety_issue>
    <description>The surgeon's ability to achieve a staple line at the desired level of the rectum.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Distal Margins</measure>
    <time_frame>Operative</time_frame>
    <safety_issue>No</safety_issue>
    <description>The ability to achieve adequate distal margins (defined as &gt;2cm [or &gt;1cm with clear histologic evaluation]) in the low rectum.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Usability</measure>
    <time_frame>Operatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>Access measured by surgeon usability questionnaire.
Visibility measured by surgeon usability questionnaire.
Maneuverability measured by surgeon usability questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Low Anterior Resection</condition>
  <condition>Proctosigmoid Resection</condition>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>Covidien Radial Reload Stapler</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Covidien Radial Reload Stapler</intervention_name>
    <arm_group_label>Covidien Radial Reload Stapler</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The subject is able to understand and sign Informed Consent Form.

          2. The subject is between 18-85 years of age.

          3. The subject is anticipated to undergo a resection of the rectum with anastomosis
             below the peritoneal reflection for the treatment of rectal cancer.

          4. The subject is anticipated to undergo mobilization and stapling of the rectum through
             an open incision.

        Exclusion Criteria:

          1. Any female patient, who is pregnant, suspected pregnant, or nursing.

          2. The participant is unable or unwilling to comply with the study requirements,
             follow-up schedule.

          3. The participant has co-morbidities which, in the opinion of the investigator, will
             not be appropriate for the study.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jessica Chowaniec</last_name>
    <phone>203-821-4741</phone>
    <email>jessica.chowaniec@covidien.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jessica Carlson</last_name>
    <phone>203-821-4734</phone>
    <email>jessica.carlson@covidien.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaun Crittenden</last_name>
      <phone>813-844-4069</phone>
    </contact>
    <investigator>
      <last_name>Sowsan H. Rasheid, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christopher Mantyh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Providence Medical Center</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Milton</last_name>
      <phone>509-474-4323</phone>
    </contact>
    <investigator>
      <last_name>M. Shane McNevin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 7, 2014</lastchanged_date>
  <firstreceived_date>October 26, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>rectal cancer</keyword>
  <keyword>stapler</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
